Sightful Invest
  • Business
  • Investing
  • Politics
  • Stock
Top Posts
Dem Senate primary erupts in key state as...
Trump-backed candidate aims to pad GOP’s fragile House...
White House unleashes on Stacey Abrams in latest...
Ilhan Omar calls Trump an ‘unhinged lunatic,’ urges...
Former Virginia Gov Glenn Youngkin hints at political...
Trump’s apocalyptic Iran warning raises stakes for sweeping...
Graham eyes ‘down payment’ on Trump-backed SAVE Act...
Midterm alarm bells: Democrats face steep favorability deficit...
Democrat whose parents fled Iran moves to oust...
American journalist kidnapped in Iraq is set free,...
  • Business
  • Investing
  • Politics
  • Stock

Sightful Invest

Politics

Trump has higher approval rating than at any point during first term: poll

by admin February 11, 2025
February 11, 2025
Trump has higher approval rating than at any point during first term: poll

President Donald Trump has the highest approval rating now compared to any point during his first term in office, according to a new poll. 

Forty-seven percent of Americans approve of Trump’s job performance in the less than a month since he was sworn in as the 47th president, the latest national survey by the Pew Research Center found. 

While that’s higher than at any point while he served as the 45th president, Trump’s inaugural approval rating sinks below that of most other presidents since Ronald Reagan. George W. Bush’s approval rating early in his second term, however, was about the same as that of Trump now. 

The poll, conducted Jan. 27 to Feb. 2 among 5,086 adults, found nearly three in ten adults, or 28%, view Trump’s actions as better than expected, while 36% said they have been what they expected. 

His actions are viewed as worse than expected by 35% of adults. 

Americans are fairly evenly split over how they believe Trump’s White House will affect the federal government. The survey found 41% of adults said they believe Trump’s administration will improve the way the federal government works, and 42% said they believe the state of the federal government will worsen with him in office. 

Public opinion on Trump’s agenda remains starkly divided along partisan lines. The poll found 67% of Republicans, including those who lean red, support all or most of Trump’s plans and policies. For Democrats and those who lean blue, 84% support few or none. Almost an identical share of Republicans, 76%, said Trump will improve the way the federal government operates, as Democrats, 78%, said Trump will make the federal government run worse. 

For Republicans, 53% viewed Trump’s recent actions as better than expected, while the poll found 60% of Democrats view the president’s accomplishments as worse than expected. 

As Trump enters his fourth week back in office, his efforts to slash wasteful federal government spending through the Department of Government Efficiency (DOGE) have caused a stir in Washington. 

His threat of tariffs against Canada and Mexico and levied against China over the flow of deadly fentanyl across American borders has similarly raised concerns. Trump’s angling for the Panama Canal and Greenland amid the increasing Chinese presence in the Western Hemisphere, as well as his administration overseeing a collapsing ceasefire agreement between Hamas and Israel in the Middle East have put the world on notice. 

Trump’s advisers are expected to meet with Ukrainian President Volodymyr Zelenskyy this week in Munich as the war with Russia stretches into its third year. Raging wildfires in California, a deadly military helicopter-passenger jet collision in D.C., and the continuing aftermath of last year’s hurricane devastation in the southeast, particularly in North Carolina, are putting Trump’s new Cabinet chiefs to the test on the domestic front, as is Trump’s crackdown on criminal illegal immigration. 

This post appeared first on FOX NEWS

previous post
Russia says US relations ‘on the brink of a breakup,’ won’t confirm Trump-Putin talk
next post
Democrat lawmaker freezes on House floor after suffering adverse reaction to medication

You may also like

Political world reacts to former President Biden’s ‘aggressive’...

May 19, 2025

Harris’ support for Palestinian state rewards terrorism, experts...

September 12, 2024

‘Access granted’: Biden’s free vacation at friend’s California...

August 23, 2024

Trump taps Richard Grenell as presidential envoy for...

December 15, 2024

Ecstatic House Republicans cry unity after Trump speech...

January 28, 2025

Trump kicks off whirlwind week marking his 100th...

April 28, 2025

Trump, lawmakers react after ‘big, beautiful bill’ clears...

June 29, 2025

Harris recruits pop stars Usher, Lizzo for swing...

October 20, 2024

Poll position: Where Trump stands in the eyes...

June 19, 2025

Trump administration accused of violating court order by...

April 2, 2026

Recent Posts

  • Dem Senate primary erupts in key state as candidate teams up with radical streamer: ‘America deserved 9/11’
  • Trump-backed candidate aims to pad GOP’s fragile House majority battle in showdown for MTG’s seat
  • White House unleashes on Stacey Abrams in latest clash over Trump’s election order
  • Ilhan Omar calls Trump an ‘unhinged lunatic,’ urges booting him out of office
  • Former Virginia Gov Glenn Youngkin hints at political future, says he’s ‘chomping at the bit’ after exit

    Sign up for our newsletter to receive the latest insights, updates, and exclusive content straight to your inbox! Whether it's industry news, expert advice, or inspiring stories, we bring you valuable information that you won't find anywhere else. Stay connected with us!


    By opting in you agree to receive emails from us and our affiliates. Your information is secure and your privacy is protected.

    Categories

    • Business (1,017)
    • Investing (4,320)
    • Politics (5,303)
    • Stock (4)
    • About us
    • Contact us
    • Privacy Policy
    • Terms & Conditions

    Disclaimer: sightfulinvest.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

    Copyright © 2026 Sightful Invest. All Rights Reserved.